J. Todd Arnedt, Ph.D. Assistant Professor of Psychiatry and Neurology Director, Behavioral Sleep Medicine Program University of Michigan, Ann Arbor, MI Other Names for Seasonal Affective Disorder (SAD) Winter Depression Seasonal Depression Major Depression with a Seasonal Pattern Characteristics of SAD Most commonly subtype of MDD, but can also apply to Bipolar I and Bipolar II disorder (with Seasonal Pattern) Predictable onset (September-October) and offset (March-April) with absence of symptoms in summer – rarely can be recurrent summer depressive episodes Seasonal pattern evident for the last 2 years, without nonseasonal depressive episodes Seasonal episodes must outnumber nonseasonal episodes Does not apply when pattern better explained by seasonal psychosocial stressors (e.g., seasonal unemployment) What are the symptoms of SAD? Typical symptoms of depression develop in fall or early winter: low mood, anhedonia, poor concentration, low energy, fatigue Atypical vegetative symptoms: increased sleep, appetite, weight gain, carbohydrate craving, leaden paralysis Irritability with more alcohol use SAD Symptoms http://www.medscape.org/viewarticle/508141 Clinical features of SAD http://www.medscape.org/viewarticle/508141 How common is SAD? 1-3 % prevalence 10-20% of Americans have some symptoms More common as we get closer to the poles Rare within 30 degrees of the equator http://www.medscape.org/viewarticle/508141 SAD relationship with latitude http://www.medscape.org/viewarticle/508141 Causes of SAD: Short photoperiod http://www.medscape.org/viewarticle/508141 Causes of SAD: Biological clocks Other possible causes Inappropriate phase angle rather than phase position Serotonin deficiency (5HT2C and 5HT7) supported by tryptophan depletion studies and 5HT medications Possibly NE and DA deficiency BUT need more research Genetic factors both protective from (Icelandic emigrants) and vulnerable to SAD (polymorphism in promoter region of 5-HT transporter and 5-HT 2A receptor) Treatment: Phototherapy www.cet.org SAD Treatment: Phototherapy Spectrum: 450 (blue) to 500 (blue/green) best to suppress melatonin and induce phase shifts but no definitive studies compared to broad-spectrum white light Intensity: 2,500 - 10,000 lux Timing: morning preferred although benefits have been shown at other times of the day relative to dim light controls. Duration: 30-120 min recommended, depending on intensity Optimal response rates may be seen when administered 7.5 – 9.5 hours after melatonin onset. Contraindications: retinal disease, some photosensitizing drugs, caution with h/o bipolar disorder Minor side effects and precautions of phototherapy Eye strain Headache Irritability Insomnia Rarely, hypomania or mania Horne-Östberg MorningnessEveningness Questionnaire (MEQ) Sample Questions: 4. Assuming adequate environmental conditions, how easy do you find getting up in the morning? 8. When you have no commitment the next day, at what time do you go to bed compared to your usual bedtime? 9. Suppose that you can choose you own work hours. Assume that you worked a FIVE hour day and that your job was interesting and paid by results. Which FIVE CONSECUTIVE HOURS would you select? 18. At what time of the day do you think that you reach your “feeling best” peak? Horne & Östberg. Int J Chronobiol 1976;4:97-110. Horne-Östberg MEQ: Scoring Interpretation Evening type 20 Neither type 40 Type Definitely Evening Moderately Evening Neither Moderately Morning Definitely Morning 60 Morning type 80 Score 16-30 31-41 42-58 59-69 70-86 Timing of Light Therapy MEQ Score Start Time MEQ Score Start Time 16-18 0845 54-57 0615 19-22 0830 58-61 0600 23-26 0815 62-65 0545 27-30 0800 66-68 0530 31-34 0745 69-72 0515 35-38 0730 73-76 0500 39-41 0715 77-80 0445 42-45 0700 81-84 0430 46-49 0645 85-86 0415 50-53 0630 10,000 lux, 30-minute session, about 8.5 hours after melatonin onset Terman & Terman, In Principles and Practice of Sleep Medicine, 4th Ed, 1424-42, 2005 Phototherapy treatment and prevention of SAD Start using light box in October Go outside! Sit by windows when possible Regular sleep pattern, especially rise time Limit alcohol Ask your family or friends to help monitor severity of your symptoms Antidepressant medication Rx for SAD Sertraline [Zoloft] (N = 187) and fluoxetine [Prozac] (N = 68) both shown effective Other SSRI (citalopram [Celexa]) and SNRI (duloxetine [Cymbalta]) medications have been tested in open label studies Bupropion XL [Wellbutrin] (N = 1042) shown effective and approved by F.D.A. in 2006 3 placebo-controlled clinical trials 150-mg once daily in the morning and titrated to 300 mg/day (target dose) after 1 week if tolerated. Acute treatment of SAD 96 patients with DSM-IV SAD studied over 3 consecutive winters 8 weeks of double-blind treatment 2 treatment conditions: 10,000-lux 30-min morning light plus placebo 100-lux plus fluoxetine 20 mg/day Lam RW. Am J Psychiatry 2006;163:805-12. Preventive treatment of SAD 1042 SAD patients received bupropion XL 150-300 mg or placebo from fall (Sept to Nov) until spring (March) in 3 prevention RCTs Modell JG. Biol Psychiatry 2005;58:658-67. Other potential treatments Naturalistic dawn simulation High-density negative air ionization Physical exercise Cognitive-behavioral therapy (CBT) Treatments can be combined for maximum benefit (e.g., light therapy with antidepressants, light therapy with CBT) Major Depressive Disorder (MDD) and SAD MDD often gets worse in winter This is NOT just SAD MDD should be treated with medications and Cognitive Behavioral Therapy or Interpersonal Psychotherapy. Phototherapy may be used to help seasonal flare-ups but light therapy should not replace other needed treatments Consult your clinician When should light therapy be used? Depression is mild Good adherence, able to make time commitment Medications contraindicated (e.g., pregnancy, breast feeding) Cost considerations: Greater initial cost and insurance coverage is variable. When should medication be used? Depression is severe or suicidality is present Depression episodes during summer, don’t end in spring (can supplement with light therapy) No response to or relative contraindications to light therapy (e.g., retinal disease, photosensitizing drug) Cost considerations Conclusions SAD is a serious psychiatric disorder with significant morbidity and reduced quality of life for patients. Causes of SAD are still under investigation but circadian rhythm, neurotransmitter, and genetic factors all likely contribute Safe and effective medication and non-medication treatments for SAD exist and can be combined for maximum benefit. Some patients may benefit from preventive treatment. Resources Rosenthal NE. Winter Blues: Everything You Need to Know to Beat Seasonal Affective Disorder, 2005 Center for Environmental Therapeutics: www.cet.org Society for Light Treatment and Biological Rhythms: www.sltbr.org Seasonal Affective Disorder Association: www.sada.org.uk